Follow-up of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia
NCT02896829
·
clinicaltrials.gov ↗
COMPLETED
Status
97
Enrollment
OTHER
Sponsor class
Conditions
Chronic Myeloid Leukemia
Interventions
BEHAVIORAL:
Interruption of the treatment by Imatinib
Sponsor
University Hospital, Bordeaux